Dabigatran for Stroke Prevention in Nonvalvular Atrial Fibrillation: Answers to Challenging ＂Real-World＂ Questions

Dabigatran etexilate is a novel, oral, reversible, direct thrombin inhibitor that constitutes a major breakthrough for stroke prevention in patients with nonvalvular atrial fibrillation (AF). Dabigatran was the first new oral anticoagulant approved in Europe and became available in Portugal, for str...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis 2012-01, Vol.2012 (2012), p.269-278
Hauptverfasser:	Ferreira, Jorge, Ferreira, Daniel, Viana-Baptista, Miguel, Bettencourt, Paulo, Cernadas, Rui, Crespo, Francisco
Format:	Artikel
Sprache:	eng
Schlagworte:	Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!